Autologous hematopoietic stem cell transplantation for autoimmune diseases (Q63214396)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Autologous hematopoietic stem cell transplantation for autoimmune diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

9 January 2020

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ina Kötter

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

6

D Farge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

20

N M Wulffraat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

A Gratwohl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

C Bocelli-Tyndall

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A Fassas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J M van Laar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

M Andolina

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

R Arnold

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

E Carreras

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J Finke

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

T Kozak

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

I Lisukov

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

B Löwenberg

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A Marmont

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J Moore

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

R Saccardi

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J A Snowden

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

F van den Hoogen

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

X W Zhao

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A Tyndall

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

869-879

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765114%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704892

9 January 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Stem cell transplantation for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Stem cell transplantation for autoimmune disorders. Preclinical experiments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Treatment of autoimmune diseases by hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous stem cell transplantation for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous stem cell transplantation in the treatment of refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Prolonged remission state of refractory adult onset Still's disease following CD34-selected autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Haemopoietic stem-cell transplantation for juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous peripheral blood stem cell transplantation in a patient with severe mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

High-dose immunosuppressive therapy and autologous progenitor cell transplantation for systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

Hematopoietic cell transplantation for benign hematological disorders and solid tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021

High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704892

7 January 2021